adenosine has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (38.46) | 29.6817 |
2010's | 7 (53.85) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Džubák, P; Gurská, S; Hajdúch, M; Hejtmánková, K; Hocek, M; Lišková, B; Oždian, T; Pohl, R; Smoleń, S; Tichý, M; Tloušt'ová, E | 1 |
Gokhale, NS; Holley, CL; Horner, SM; Lazear, HM; Mason, CE; Mattocks, MD; McIntyre, ABR | 1 |
Babusis, D; Birkus, G; Cho, A; Eng, S; Fenaux, M; Feng, JY; Kirschberg, T; Park, Y; Ray, AS; Tirunagari, N; Voitenleitner, C; Wang, T; Xu, Y; Yang, H | 1 |
Balsarotti, J; Briley, A; Dufner-Beattie, J; Noueiry, A; O'Guin, A; O'Guin, S; Olivo, PD; Rice, CM; Roth, R; Slomczynska, U; Starkey, G; Wang, B | 1 |
Luo, R; Nong, J; Qing, J; Shao, Y; Sun, Y; Tang, R; Wang, Y; Wu, M; Yin, Z; Yu, X | 1 |
Amblard, F; Amiralaei, S; Cho, JH; Coats, SJ; Domaoal, RA; Ehteshami, M; Khalil, A; Lee, SS; Lin, B; Lu, X; Ozturk, T; Schinazi, RF; Shelton, JR; Stanton, RA; Suesserman, JE; Tao, S; Whitaker, T; Zhang, H; Zhou, L | 1 |
Cappellacci, L; Grifantini, M; Petrelli, R | 1 |
Frezza, BM; Ghadiri, MR; Picuri, JM | 1 |
Manvar, D; Pandey, VN; Singh, K | 1 |
Bhat, B; Bosserman, M; Carroll, SS; De Francesco, R; Eldrup, AB; Getty, K; Hall, D; Kuo, LC; LaFemina, R; MacCoss, M; Migliaccio, G; Olsen, DB; Rutkowski, CA; Simcoe, AL; Stahlhut, MW; Tomassini, JE; Wolanski, B; Yang, Z | 1 |
Darnell, ME; Feinstone, SM; Mihalik, K; Puig, M; Taylor, DR | 1 |
Boyer, SH; Erion, MD; Fujitaki, JM; Hecker, SJ; Huang, W; Koeplinger, KA; Linemeyer, DL; MacCoss, M; Olsen, DB; Reddy, KR; Reddy, MV; Sun, Z; van Poelje, PD; Varkhedkar, V | 1 |
Kay, MA; Lancaster, AM; Lukavsky, PJ; McCaffrey, AP; Meuse, L; Ohashi, K; Sarnow, P; Shen, S | 1 |
1 review(s) available for adenosine and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
Article | Year |
---|---|
Development of C-Methyl Branched Purine Ribonucleoside Analogs: Chemistry, Biological Activity and Therapeutic Potential.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Antineoplastic Agents; Hepacivirus; Hepatitis C; Humans; Molecular Docking Simulation; Multiple Myeloma; Purine Nucleotides; Receptor, Adenosine A1; Structure-Activity Relationship | 2016 |
12 other study(ies) available for adenosine and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
Article | Year |
---|---|
Synthesis and Cytostatic and Antiviral Profiling of Thieno-Fused 7-Deazapurine Ribonucleosides.
Topics: Antineoplastic Agents; Antiviral Agents; Cell Line, Tumor; Hepacivirus; Hepatitis C; Humans; Neoplasms; Purines; Ribonucleosides | 2017 |
Altered m
Topics: Adenosine; Cell Line; Dengue; Dengue Virus; Flaviviridae; Flaviviridae Infections; Hepacivirus; Hepatitis C; Host-Pathogen Interactions; Humans; Protein Serine-Threonine Kinases; RNA-Binding Proteins; RNA, Messenger; Virus Replication; Zika Virus; Zika Virus Infection | 2020 |
Nucleotide Prodrug Containing a Nonproteinogenic Amino Acid To Improve Oral Delivery of a Hepatitis C Virus Treatment.
Topics: Adenosine; Administration, Oral; Alanine; Animals; Antiviral Agents; Caco-2 Cells; Cells, Cultured; Dogs; Hepacivirus; Hepatitis C; Humans; Male; Nucleotides; Prodrugs; Rats; Triazines; Virus Replication | 2018 |
Identification of AP80978, a novel small-molecule inhibitor of hepatitis C virus replication that targets NS4B.
Topics: Adenosine; Antiviral Agents; Biological Assay; Cell Culture Techniques; Cell Line; Cell Survival; Cyclosporine; Furans; Genotype; Hepacivirus; Hepatitis C; High-Throughput Screening Assays; Humans; Luciferases, Renilla; Mutagenesis, Site-Directed; Oligopeptides; Pyridines; Replicon; Thiophenes; Viral Nonstructural Proteins; Virus Replication | 2014 |
Resistance analysis and characterization of NITD008 as an adenosine analog inhibitor against hepatitis C virus.
Topics: Adenosine; Antiviral Agents; Cell Line; Drug Resistance, Viral; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Mutation; Oligopeptides; Protease Inhibitors; Replicon; Ribavirin; RNA, Viral; Sofosbuvir; Viral Nonstructural Proteins; Virus Replication | 2016 |
Biochemical Characterization of the Active Anti-Hepatitis C Virus Metabolites of 2,6-Diaminopurine Ribonucleoside Prodrug Compared to Sofosbuvir and BMS-986094.
Topics: Adenosine; Antiviral Agents; Cell Line; DNA-Directed RNA Polymerases; Guanosine Monophosphate; Hepacivirus; Hepatitis C; Humans; Prodrugs; Ribonucleosides; RNA; RNA, Mitochondrial; RNA, Viral; Sofosbuvir; Transcription, Genetic; Viral Nonstructural Proteins; Virus Replication | 2016 |
Universal translators for nucleic acid diagnosis.
Topics: Adenosine; Animals; Aptamers, Nucleotide; Base Sequence; Birds; DNA; Hepatitis C; Humans; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Nucleic Acid Amplification Techniques; Polymorphism, Single Nucleotide; RNA, Viral; Smallpox | 2009 |
Affinity labeling of hepatitis C virus replicase with a nucleotide analogue: identification of binding site.
Topics: Adenosine; Adenosine Triphosphate; Affinity Labels; Amino Acid Sequence; Binding Sites; Hepacivirus; Hepatitis C; Humans; Molecular Docking Simulation; Mutagenesis; Nucleotides; Point Mutation; Protein Binding; RNA-Dependent RNA Polymerase; Sequence Alignment; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2013 |
Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs.
Topics: Adenosine; Adenosine Triphosphate; Cells, Cultured; Cytidine; Cytidine Triphosphate; DNA Polymerase beta; DNA Polymerase gamma; DNA Polymerase I; DNA-Directed DNA Polymerase; Gels; Hepacivirus; Hepatitis C; Humans; Nucleic Acid Synthesis Inhibitors; RNA, Viral; Viral Nonstructural Proteins; Virus Replication | 2003 |
New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1.
Topics: Adenosine; Cell Line, Tumor; Hepacivirus; Hepatitis C; Humans; Inosine; Interferon-alpha; Replicon; RNA Editing; RNA, Viral; Virus Replication | 2005 |
Liver-targeted prodrugs of 2'-C-methyladenosine for therapy of hepatitis C virus infection.
Topics: Adenosine; Administration, Oral; Animals; Antiviral Agents; Biological Availability; Hepatitis C; Hepatocytes; Injections, Intravenous; Liver; Organophosphates; Organophosphorus Compounds; Phosphorylation; Prodrugs; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2007 |
Determinants of hepatitis C translational initiation in vitro, in cultured cells and mice.
Topics: 3' Untranslated Regions; Adenosine; Animals; Disease Models, Animal; HeLa Cells; Hepacivirus; Hepatitis C; Humans; In Vitro Techniques; Liver; Luciferases; Mice; Placental Hormones; Polymers; Protein Biosynthesis; RNA, Messenger; RNA, Viral | 2002 |